Interestingly, dual knockout of LKB1 and PIM kinases exerts a synergistic tumor-suppressive effect, suggesting that indirect targeting of the LKB1/AMPK axis via PIM inhibition could benefit selected patients (Mung et al., 2021). Here, PIM1 is linked to neoplasm.